Evidence map›Paper›PMID 31162002›Full record

ArticleBJPsych bulletin2020

Standard smoking cessation services in sites participating in the SCIMITAR+ trial for people with severe mental ill health.

Paul Heron, Tayla McCloud, Catherine Arundel, Della Bailey, Suzy Ker, Jinshuo Li, Masuma Mishu, David Osborn, Steve Parrott, Emily Peckham and 2 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJPsych bulletin, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Paul HeronMental Health and Addiction Research Group, University of York, UK.
Tayla McCloudDivision of Psychiatry, University College London, UK.
Catherine ArundelYork Trials Unit, University of York, UK.
Della BaileyMental Health and Addiction Research Group, University of York, UK.
Suzy KerHuntington House Mental Health Resource Centre, Tees, Esk and Wear Valleys NHS Foundation Trust, UK.
Jinshuo LiMental Health and Addiction Research Group, University of York, UK.
Masuma MishuMental Health and Addiction Research Group, University of York, UK.
David OsbornDivision of Psychiatry, University College London, UK.
Steve ParrottMental Health and Addiction Research Group, University of York, UK.
Emily PeckhamMental Health and Addiction Research Group, University of York, UK.
Alison StriblingWindsor Research Unit, Cambridgeshire and Peterborough NHS Foundation Trust, UK.
Simon GilbodyMental Health and Addiction Research Group, University of York, UK.
University of York · GBUniversity College London · GBCambridgeshire and Peterborough NHS Foundation Trust · GBTees, Esk and Wear Valleys NHS Foundation Trust · GB

Funding

Department of Health HTA/11/136/52
6 · The paper itself

Abstract

Aims and methodThe SCIMITAR+ trial was commissioned to evaluate the effectiveness of a bespoke smoking cessation intervention for people with severe mental ill health compared with usual services. It is difficult to define what constitutes usual care in smoking cessation services. We aimed to define what this was during the trial. Twenty-two National Health Service healthcare providers participated in a bespoke survey asking about usual care in their area.

resultsAll sites offered smoking cessation support; however, service provider and service type varied substantially. In some cases services were not streamlined, meaning that people received smoking cessation counselling from one organisation and smoking cessation medication from another.Clinical implicationsTo better implement the National Institute for Health and Care Excellence guideline PH48, clearer referral pathways need to be implemented and communicated to patients, staff and carers. People with severe mental ill health need to be able to access services that combine nicotine replacement therapy and behavioural support in a streamlined manner.Declaration of interestNone.

Indexed as

bipolar affective disordersnicotine replacement therapyschizophreniaSevere mental ill healthsmoking cessation

Identifiers

PMID31162002
PMCPMC12402911
OpenAlexW2948976356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.